Načítá se...

Performance of the New Bayer VERSANT HCV RNA 3.0 Assay for Quantitation of Hepatitis C Virus RNA in Plasma and Serum: Conversion to International Units and Comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, Assay

We have evaluated the VERSANT HCV RNA 3.0. Assay (HCV 3.0 bDNA assay) (Bayer Diagnostics, Berkeley, Calif.), which is an improved signal amplification procedure for the HCV 2.0 bDNA assay for the quantitation of hepatitis C virus (HCV) RNA in serum or plasma of HCV-infected individuals. The HCV 3.0...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Beld, Marcel, Sentjens, Roel, Rebers, Sjoerd, Weegink, Christine, Weel, Jan, Sol, Cees, Boom, René
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2002
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC120248/
https://ncbi.nlm.nih.gov/pubmed/11880394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.40.3.788-793.2002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!